BioNTech SE’s founders will leave the company to start a new biotech focused on messenger RNA, the technology behind their ...

BioNTech's co-founders, Ugur Sahin and Oezlem Tuereci, plan to leave by year's end to start a new venture, causing BioNTech's shares to plummet. The couple aims to focus on mRNA-based drugs at an ...

Right before BioNTech was due to announce its 2025 results, the company’s co‑founders, Ugur Sahin and Özlem Türeci, revealed they would leave the company to focus on develop ...

BioNTech SE’s founders will leave the company to start a new biotech focused on messenger RNA, the technology behind their ...

BioNTech's co-founders, Ugur Sahin and Oezlem Tuereci, will leave the company by 2026 to establish a new venture focused on next-generation mRNA drugs. Although BioNTech's stock plummeted following ...

In January last year, German biotech company BioNTech acquired African AI startup InstaDeep for over $550 million, a deal finalized in July of the same year. InstaDeep, whose exit is currently the ...

Acquisition aims to strengthen the research, development, manufacturing and commercialization of mRNA-based cancer immunotherapy candidates, marking BioNTech’s next milestone in the execution of its ...